Derrimon Shareholders Approve $4.8-Billion APO

September 30, 2020

The way is now clear for Derrimon Trading Limited to approach the equities market with another public offering (APO) of shares to raise what is believed to be as much as $4.8 billion.

This following last Friday’s (September 25) approval by shareholders of four resolutions at the company’s annual general meeting (AGM) held on September 25, 2020 at Knutsford Court Hotel in Kingston.

The resolution authorises the company’s board and management to “issue up to 1.8 billion ordinary shares by way of an offer for subscription to the public pursuant to a prospectus (herein an additional public offering) in lieu of a rights issue to existing stockholders”.

At the current trading rate of Derrimon stocks at $2.70 and without any discount, 1.8 million shares would fetch $4.86 billion.

Shareholders have also mandated the board and management to determine, in their discretion, any terms and conditions relating to the APO. Any pre-emption rights to which the existing stockholders may be entitled have been “disapplied” for the purposes of the APO, based on a resolution approved by shareholders.

The proceeds of the fund-raising event will be used for expansion capital and to write down debt. The APO is expected to hit the market sometime in late October to early November, with the prospectus being published within the next two to three weeks.

 

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

 

More Stories from the Market
shutterstock_537598660
March 24, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the first quarter ended January 31, 2026: Indies Pharma Jama…
shutterstock_609342323
March 24, 2026   Indies Pharma Jamaica Limited (INDIES) has declared an interim dividend of $0.135 per stock unit payable on April 30, 2026…
shutterstock_453968572
March 24, 2026   Kintyre Holdings (JA) Limited (KNTYR) has advised that Visual Vibe Limited has entered into a strategic partnership with K…
shutterstock_148562033
March 24, 2026   Sagicor Group Jamaica Limited (SJ) has advised that an Executive sold 5,000 SJ shares on March 23, 2026.   Di…
shutterstock_148562033
March 24, 2026   JMMB Group Limited (JMMBGL) has advised of the purchase of 49,705 JMMBGL shares on March 19, 2026, under the Company’s sha…
shutterstock_453968572
March 24, 2026   A.S. Bryden & Sons Holdings Limited (ASBH) has advised of the appointment of Mr. John De Silva to the position of Grou…
shutterstock_453968572
March 24, 2026   United States: US Business Activity Growth Cools as Prices Rise on Iran War   Growth in US business activity slow…
shutterstock_453968572
March 23, 2026   Sagicor Real Estate X Fund Limited (XFUND) has advised that the Board of Directors intends to convene a meeting on Monday,…